Holly Hall

Doctor of Medicine,  Mayo Clinic - Rochester 

Location: United States

Consulting Services

Grant Submission Research Consulting Pharma-CRO-Device Case Consulting Career Advice and Mentoring

Areas Of Interest

Gelcen Mast Cell Diseases Stem Cells, Somatic Benzoylarginine Nitroanilide, Monosodium Salt, Monohydrochloride Fibromatosis, Abdominal Ligases, Carbon-Oxygen Dropworts, Water Reductase, Progesterone Skin Syphilis Hepatitis A Male Circumcisions Syndrome, Tonelessness Stomach Cancer Cryotherapies Kasabach Merritt Phenomenon Activin Receptor Like Kinase 3 Eczemas, Dyshydrotic Infection, Genital Tract Twitter Messaging Spectroscopy, Mass, Secondary Ion Pentosane Sulfuric Polyester Low Income Population Schoenlein Henoch Purpura Granuloma, Dental v-src Genes Ventricle Remodeling Hyperlipoproteinemia Type IIa Thienamycins Renal Tubular Acidosis I Odontogenic Tumors, Squamous Class I Major Histocompatibility Molecules Biofeedbacks (Psychology) Crabgrass Acetate, Diethylaminoethyldiphenylpropyl Lafora Body Disorder Coxsackieviruses B Xylesthesin Myeloid Leukemias, Ph1-Negative Nose Neoplasm MPS3A

Professional Narrative

Dr. Holly Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Mayo Clinic 2001
Senior Director, Amgen 2015

Education

Master of Science in physician assistant, Baylor College 1992
Bachelor of science in nursing, Yale School of Medicine 1994

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :